Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives

References

• Chakera AJ , Spyer G , Vincent N , et al. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic diabetes in pregnancy cohort. Diabetes Care . 2014;37:1230–1236. doi:10.2337/dc13-2248 24550216
   PubMed Web of Science ®Google Scholar
• Kawakita R , Hosokawa Y , Fujimaru R , et al. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients. Diabetic Med . 2014;31:1357–1362. doi:10.1111/dme.12487 24804978
   PubMed Web of Science ®Google Scholar
• Xu JY , Dan QH , Chan V , et al. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Eur J Hum Genet . 2005;13:422–427. doi:10.1038/sj.ejhg.5201347 15657605
   PubMed Web of Science ®Google Scholar
• McCarthy MI , Hattersley AT . Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes. Diabetes . 2008;57:2889–2898. doi:10.2337/db08-0343 18971436
   PubMed Web of Science ®Google Scholar
• Shields BM , Hicks S , Shepherd MH , et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia . 2010;53:2504–2508. doi:10.1007/s00125-010-1799-4 20499044
   PubMed Web of Science ®Google Scholar
• Osbak KK , Colclough K , Saint-Martin C , et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat . 2009;30:1512–1526. doi:10.1002/humu.21110 19790256
   PubMed Web of Science ®Google Scholar
• Gasperikova D , Tribble ND , Stanik J , et al. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (−71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans. Diabetes . 2009;58:1929–1935. doi:10.2337/db09-0070 19411616
   PubMed Web of Science ®Google Scholar
• Ellard S , Thomas K , Edghill EL , et al. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia . 2007;50:2313–2317. doi:10.1007/s00125-007-0798-6 17828387
   PubMed Web of Science ®Google Scholar
• Stride A , Vaxillaire M , Tuomi T , et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia . 2002;45:427–435. doi:10.1007/s00125-001-0770-9 11914749
   PubMed Web of Science ®Google Scholar
• Burke CV , Buettger CW , Davis EA , et al. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). Biochem J . 1999;342:345–352.10455021
   PubMed Web of Science ®Google Scholar
• Sturis J , Kurland IJ , Byrne MM , et al. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations. Diabetes . 1994;43:718–723. doi:10.2337/diab.43.5.718 8168650
   PubMed Web of Science ®Google Scholar
• Chakera AJ , Steele AM , Gloyn AL , et al. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care . 2015;38:1383–1392. doi:10.2337/dc14-2769 26106223
   PubMed Web of Science ®Google Scholar
• Byrne MM , Sturis J , Clement K , et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest . 1994;93:1120–1130. doi:10.1172/JCI117064 8132752
   PubMed Web of Science ®Google Scholar
• Kelly A , Li C , Gao Z , et al. Glutaminolysis and insulin secretion: from bedside to bench and back. Diabetes . 2002;51:S421–S426. doi:10.2337/diabetes.51.2007.s421 12475785
   PubMed Web of Science ®Google Scholar
• Velho G , Froguel P , Clement K , et al. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet . 1992;340:444–448. doi:10.1016/0140-6736(92)91768-4 1354782
   PubMed Web of Science ®Google Scholar
• Ellard S , Bellanne-Chantelot C , Hattersley AT . European Molecular Genetics Quality Network MODY Group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia . 2008;51:546–553. doi:10.1007/s00125-008-0942-y 18297260
   PubMed Web of Science ®Google Scholar
• Guenat E , Seematter G , Philippe J , et al. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations. Diabetes Metab . 2000;26:377–384.11119017
   PubMed Web of Science ®Google Scholar
• Velho G , Petersen KF , Perseghin G , et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest . 1996;98:1755–1761. doi:10.1172/JCI118974 8878425
   PubMed Web of Science ®Google Scholar
• Gloyn AL , Noordam K , Willemsen MA , et al. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes . 2003;52:2433–2440. doi:10.2337/diabetes.52.9.2433 12941786
   PubMed Web of Science ®Google Scholar
• Steele AM , Wensley KJ , Ellard S , et al. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. PLoS One . 2013;8:e65326. doi:10.1371/journal.pone.0065326 23799006
   PubMed Web of Science ®Google Scholar
• Steele AM , Shields BM , Wensley KJ , et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA . 2014;311:279–286. doi:10.1001/jama.2013.283980 24430320
   PubMed Web of Science ®Google Scholar
• Shepherd M , Hattersley AT . ‘I don’t feel like a diabetic any more’: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clin Med (Northfield Il) . 2004;4:144–147. doi:10.7861/clinmedicine.4-2-144
   PubMed Web of Science ®Google Scholar
• Shepherd M , Colclough K , Ellard S , et al. Ten years of the national genetic diabetes nurse network: a model for the translation of genetic information into clinical care. Clin Med (Northfield Il) . 2014;14:117–121. doi:10.7861/clinmedicine.14-2-117
   Web of Science ®Google Scholar
• Diabetes Research Department and the Centre for Molecular Genetics at the University of Exeter Medical School and Royal Devon and Exeter Hospital, UK. Guidelines for genetic testing in MODY. Available from: https://www.diabetesgenes.org/tests-for-diabetes-subtypes/guidelines-for-genetic-testing-in-mody/. Accessed 3 27, 2019.
   Google Scholar
• Shields BM , Shepherd M , Hudson M , et al. Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care . 2017;40:1017–1025. doi:10.2337/dc17-0224 28701371
   PubMed Web of Science ®Google Scholar
• Patel KA , Weedon MN , Shields BM , et al. Zinc transporter 8 autoantibodies (ZnT8A) and a type 1 diabetes genetic risk score can exclude individuals with type 1 diabetes from inappropriate genetic testing for monogenic diabetes. Diabetes Care . 2019;42:e16–e17. doi:10.2337/dc18-0373 30409810
   PubMed Web of Science ®Google Scholar
• Thomson KL , Gloyn AL , Colclough K , et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat . 2003;22:417. doi:10.1002/humu.9173
   Google Scholar
• Diabetes Research Department and the Centre for Molecular Genetics at the University of Exeter Medical School and Royal Devon and Exeter Hospital, UK. GCK gene analysis in maturity-onset diabetes of the young (GCK MODY). Available from: https://www.diabetesgenes.org/what-is-mody/gck-gene-analysis-in-maturity-onset-diabetes-of-the-young-gck-mody/. Accessed 3 27, 2019.
   Google Scholar
• Sellner LN , Taylor GR . MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat . 2004;23:413–419. doi:10.1002/humu.20035 15108271
   PubMed Web of Science ®Google Scholar
• Diabetes Research Department and the Centre for Molecular Genetics at the University of Exeter Medical School and Royal Devon and Exeter Hospital, UK. Targeted next generation sequencing. Available from: https://www.diabetesgenes.org/tests-for-diabetes-subtypes/targeted-next-generation-sequencing-analysis-of-45-monogenic-diabetes-genes/#. Accessed 5 31, 2019.
   Google Scholar
• Rudland VL , Hinchcliffe M , Pinner J , et al. Identifying glucokinase monogenic diabetes in a multiethnic gestational diabetes mellitus cohort: new pregnancy screening criteria and utility of HbA1c. Diabetes Care . 2016;39:50–52. doi:10.2337/dc15-1001 26109503
   PubMed Web of Science ®Google Scholar
• Wang Z , Ping F , Zhang Q , et al. Preliminary screening of mutations in the glucokinase gene of Chinese patients with gestational diabetes. J Diabetes Investig . 2018;9:199–203. doi:10.1111/jdi.12664
   Web of Science ®Google Scholar
• Diabetes Research Department and the Centre for Molecular Genetics at the University of Exeter Medical School and Royal Devon and Exeter Hospital, UK. The management of pregnancy in patients with hyperglycaemia due to mutations of the glucokinase (GCK) gene: GCK and pregnancy guidelines 18.01.2018. Available from: https://www.diabetesgenes.org/what-is-mody/what-is-glucokinase-gck/. Accessed 3 27, 2019.
   Google Scholar
• Ellard S , Beards F , Allen LI , et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia . 2000;43:250–253. doi:10.1007/s001250050038 10753050
   PubMed Web of Science ®Google Scholar
• Hattersley AT , Pearson ER . Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology . 2006;147:2657–2663. doi:10.1210/en.2006-0152 16556760
   PubMed Web of Science ®Google Scholar
• Chakera AJ , Hurst PS , Spyer G , et al. Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes. Mol Metab . 2018;17:17–27. doi:10.1016/j.molmet.2018.08.001 30146176
   PubMed Web of Science ®Google Scholar
• Stride A , Shields B , Gill-Carey O , et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia . 2014;57:54–56. doi:10.1007/s00125-013-3075-x 24092492
   PubMed Web of Science ®Google Scholar
• Shepherd MH , Shields BM , Hudson M , et al. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Diabetologia . 2018;61:2520–2527. doi:10.1007/s00125-018-4728-6 30229274
   PubMed Web of Science ®Google Scholar
• Shepherd M . Genetic testing in maturity onset diabetes of the young (MODY) - practical guidelines for professionals. Pract Diab Int . 2003;20:103–110. doi:10.1002/pdi.458
   Google Scholar
• Bell R , Glinianaia SV , Tennant PW , et al. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia . 2012;55:936–947. doi:10.1007/s00125-012-2455-y
   Web of Science ®Google Scholar
• Spyer G , Macleod KM , Shepherd M , et al. Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabetic Med . 2009;26:14–18. doi:10.1111/j.1464-5491.2008.02622.x 19125755
   PubMed Web of Science ®Google Scholar
• Hattersley AT , Beards F , Ballantyne E , et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet . 1998;19:268–270. doi:10.1038/953 9662401
   PubMed Web of Science ®Google Scholar
• Spyer G , Hattersley AT , Sykes JE , et al. Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol . 2001;185:240–241. doi:10.1067/mob.2001.113127 11483936
   PubMed Web of Science ®Google Scholar
• Pedersen J . Diabetes and pregnancy; blood sugar of newborn infants during fasting and glucose administration. Nord Med . 1952;47:1049.
   PubMedGoogle Scholar
• Hosokawa Y , Higuchi S , Kawakita R , et al. Pregnancy outcome of Japanese patients with glucokinase-maturity-onset diabetes of the young. J Diabetes Investig . 2019. doi:10.1111/jdi.13046
   Web of Science ®Google Scholar
• Chen C , Xu X , Yan Y . Estimated global overweight and obesity burden in pregnant women based on panel data model. PLoS One . 2018;13:e0202183. doi:10.1371/journal.pone.0202183 30092099
   PubMed Web of Science ®Google Scholar
• Deputy NP , Dub B , Sharma AJ . Prevalence and trends in prepregnancy normal weight - 48 States, New York City, and District of Columbia, 2011–2015. MMWR . 2018;66:1402–1407. doi:10.15585/mmwr.mm665152a3 29300720
   PubMed Web of Science ®Google Scholar
• Maxwell C , Glanc P . Imaging and obesity: a perspective during pregnancy. AJR . 2011;196:311–319. doi:10.2214/AJR.10.5849 21257881
   PubMed Web of Science ®Google Scholar
• Hellebust H , Johnsen SL , Rasmussen S , et al. Maternal weight gain: a determinant for fetal abdominal circumference in the second trimester. Acta Obstet Gynecol Scand . 2011;90:666–670. doi:10.1111/j.1600-0412.2011.01129.x 21418160
   PubMed Web of Science ®Google Scholar
• Chakera AJ , Carleton VL , Ellard S , et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care . 2012;35:1832–1834. doi:10.2337/dc12-0151 22773699
   PubMed Web of Science ®Google Scholar
• Chakera AJ , Carleton VL , Shields B , et al. Response to comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care . Diabetes care. 2013;36:e15, 2012;35:1832–1834. doi:10.2337/dc12-0151 22773699
   PubMed Web of Science ®Google Scholar
• Lun FM , Tsui NB , Chan KC , et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A . 2008;105:19920–19925. doi:10.1073/pnas.0810373105 19060211
   PubMed Web of Science ®Google Scholar
• Colclough K , Saint-Martin C , Timsit J , et al. Clinical utility gene card for: maturity-onset diabetes of the young. Eur J Hum Genet . 2014;22:e1–e6. doi:10.1038/ejhg.2014.14
   Web of Science ®Google Scholar
• De Franco E , Caswell R , Houghton JA , et al. Analysis of cell-free fetal DNA for non-invasive prenatal diagnosis in a family with neonatal diabetes. Diabetic Med . 2017;34:582–585. doi:10.1111/dme.13180 27477181
   PubMed Web of Science ®Google Scholar
• Velho G , Hattersley AT , Froguel P . Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia . 2000;43:1060–1063. doi:10.1007/s001250051490 10990085
   PubMed Web of Science ®Google Scholar
• Singh R , Pearson ER , Clark PM , et al. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations. Diabetologia . 2007;50:620–624. doi:10.1007/s00125-006-0541-8 17216282
   PubMed Web of Science ®Google Scholar